Lupus autoantibodies to native DNA preferentially bind DNA presented on PolIV.
While immunoglobulin G (IgG) antibodies to double-stranded (ds)DNA are serological markers of systemic lupus erythematosus (SLE), not all antibodies to DNA (anti-DNA) are able to cause tissue damage to a similar extent. It has been proposed that anti-DNA-induced renal damage could be linked to differences in the fine specificity of the antibodies. In an attempt to gain insight into their fine binding properties, we investigated the cross-reactivity of two human lupus monoclonal IgG anti-dsDNA (B3 and RH14) to a recently described Escherichia coli PolIV (a DNA polymerase). These autoantibodies possess distinct pathogenic properties in severe combined immunodeficient (SCID) mice. Although both antibodies cause proteinuria, only RH14 induces early histological features of lupus nephritis. Both RH14 and B3 bound PolIV; however, they exhibited a marked difference in their reactivity to the PolIV-dsDNA complex. Alhough RH14 exhibited significant activity to the complex, the binding of B3 to PolIV complexed with dsDNA was almost abolished. Furthermore, there was a significant difference in the way the lupus sera recognized naked dsDNA and that presented on PolIV. Although 67% of lupus sera bound naked dsDNA, approximately 90% of these sera (93% calf thymus DNA; 90% synthetic oligonucleotide) reacted to the complex when dsDNA was presented on PolIV. Thus, the IgG anti-dsDNA likely to exist in lupus patients may be distinguished into those that recognize dsDNA in the context of PolIV and those which do not. This difference in binding ability may help to distinguish those dsDNA antibodies that are more pathogenic.
Kumar
Sanjeev
S
Centre for Rheumatology, Department of Medicine, University College London Hospital, London, UK. sanjeev.kumar@antisoma.com
Bunting
Karen A
KA
Kalsi
Jatinderpal
J
Hinks
John A
JA
Latchman
David S
DS
Pearl
Laurence H
LH
Isenberg
David A
DA
D000328:Adult; D000818:Animals; D000974:Antibodies, Antinuclear / Q000276:immunology / Q000378:metabolism*; D000918:Antibody Specificity / Q000276:immunology; D015551:Autoimmunity; D003429:Cross Reactions / Q000276:immunology; D019951:DNA Polymerase beta / Q000276:immunology; D004268:DNA-Binding Proteins / Q000378:metabolism*; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology / Q000378:metabolism; D008180:Lupus Erythematosus, Systemic / Q000276:immunology*; D008181:Lupus Nephritis / Q000276:immunology; D008297:Male; D051379:Mice; D016513:Mice, SCID; D008875:Middle Aged
D000974:Antibodies, Antinuclear; D004268:DNA-Binding Proteins; D007074:Immunoglobulin G; D019951:DNA Polymerase beta
Mol Cell. 2001 Jul;8(1):7-8
11515498
Curr Opin Microbiol. 2001 Oct;4(5):586-94
11587937
Cell. 2001 Oct 5;107(1):9-12
11595180
Arthritis Rheum. 1979 Mar;22(3):226-35
311204
J Immunol. 1981 Feb;126(2):538-9
6161179
J Immunol. 1982 Mar;128(3):1341-5
7057035
Biochemistry. 1982 Sep 28;21(20):4940-5
6182906
Mol Immunol. 1983 Jun;20(6):581-8
6192329
J Immunol. 1984 Feb;132(2):872-6
6690621
J Immunol Methods. 1985 Apr 22;78(2):191-8
2580912
Arthritis Rheum. 1985 Sep;28(9):999-1007
3876101
Immunology. 1987 Jul;61(3):375-81
3497092
Scand J Immunol. 1989 Jul;30(1):51-63
2787927
Arthritis Rheum. 1990 Feb;33(2):153-9
2407246
Annu Rev Immunol. 1992;10:731-57
1591002
Curr Opin Rheumatol. 1992 Aug;4(4):509-15
1503874
Ann Rheum Dis. 1993 Jan;52(1):14-20
8427508
Clin Exp Immunol. 1993 Apr;92(1):39-45
8385586
Medicine (Baltimore). 1993 Mar;72(2):113-24
8479324
J Immunol. 1993 Aug 1;151(3):1614-26
8393048
Q J Med. 1993 Jul;86(7):447-58
8210301
J Immunol. 1994 Mar 1;152(5):2601-12
7510750
J Clin Invest. 1995 Mar;95(3):1398-402
7883986
Clin Exp Rheumatol. 1994 Nov-Dec;12 Suppl 11:S27-31
7539349
Eur J Immunol. 1995 Jul;25(7):1897-904
7621866
J Immunol. 1996 Feb 15;156(4):1668-75
8568274
Biochemistry. 1996 Feb 6;35(5):1624-33
8634294
Methods. 1997 Jan;11(1):44-54
8990088
Br J Rheumatol. 1997 Feb;36(2):229-33
9133936
Curr Opin Rheumatol. 1997 Sep;9(5):387-92
9309193
Arthritis Rheum. 1997 Sep;40(9):1725
9324032
Eur J Immunol. 1998 Jan;28(1):339-50
9485213
J Exp Med. 1998 Jul 6;188(1):29-38
9653081
Biochemistry. 1999 Jan 12;38(2):560-8
9888795
Crit Rev Immunol. 1999;19(2):117-26
10352900
J Biol Chem. 2000 Nov 10;275(45):35129-36
10893224
Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):3838-43
10760255
Mol Cell. 1999 Aug;4(2):281-6
10488344
J Mol Biol. 2001 May 4;308(3):527-39
11327785
Mol Cell. 2001 Mar;7(3):571-9
11463382